Evaluation of Immunohistochemical Findings and Clinical Features associated with Local Aggressiveness in Basal Cell Carcinoma

Authors

  • Alireza ZeynadiniMeymand Pathology and Stem Cell Research Center, Dermatopathology Department, Afzalipour Teaching Hospital, Kerman University of Medical Sciences, Kerman, Iran
  • Mahin Aflatoonian Pathology and Stem Cell Research Center, Dermatopathology Department, Afzalipour Teaching Hospital, Kerman University of Medical Sciences, Kerman, Iran
  • Maryam Iranpour Department of Pathology, Afzalipour Teaching Hospital, Kerman University of Medical Sciences, Kerman, Iran
  • Maryam Khalili Pathology and Stem Cell Research Center, Dermatopathology Department, Afzalipour Teaching Hospital, Kerman University of Medical Sciences, Kerman, Iran
  • Shahriar Dabiri Pathology and Stem Cell Research Center, Afzalipour Teaching Hospital, Kerman University of Medical Sciences, Kerman, Iran
  • Simin Shamsi meymandi Pathology and Stem Cell Research Center, Dermatopathology Department, Afzalipour Teaching Hospital, Kerman University of Medical Sciences, Kerman, Iran
  • Sorour Alijani Department of Dermatology, Dermatopathology Department, Afzalipour Teaching Hospital, Kerman University of Medical Sciences, Kerman, Iran
Abstract:

Background & Objective:Basal cell carcinoma (BCC) is classified into BCC1 or low risk (nodular, superficial type) and BCC2 or high risk (micronodular, morpheaform, infiltrative, and basosquamous types) based on clinical behavior. This study attempts to evaluate immunohistochemical (IHC) findings and clinical features associated with local aggressiveness and recurrence in BCC lesions.Methods:This is a cross-sectional descriptive study conducted on 42 paraffin blocks (22 BCC1, 20 in BCC2) at Pathology Department of Afzalipour Teaching Hospital. First, demographic features of the patients were recorded and pathology blocks were classified by two dermatopathologists based on histopathological types of BCC1 and BCC2. Then, primary monoclonal antibodies including CD10, CD1a, SMA, Ki67, CD34, and P53 were utilized for IHC study. We compared BCC1 and BCC2 according to IHC markers, demographic features of patients, and tumoral features.Results:The mean number of Langerhans cells (LCs) within epidermis above tumor mass was 14+1.92 and 4.7±1.23 in BCC1 and BCC2, respectively; these results show a significant difference between the two groups (P=0.001). P53 was positive in 41.13±6.39% and 74.5 ±6.26% of the tumor cells in BCC1 and BCC2 groups, which was statistically significant (P=0.001). Also, the mean number of blood vessels was 14.40±1.30 and 21.40±1.97 in BCC1 and BCC2, that was statistically significant (P=0.005).Conclusion: Higher numbers of angiogenesis (SMA positive) and positive P53 were observed in BCC2 than BCC1. Also, more active positive CD1a cells were observed in BCC1 compared to BCC2.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Horrifying Basal Cell Carcinoma: Cytological, Immunohistochemical, and Ultrastructural Findings

Basal cell carcinoma (BCC) is a slow-growing and frequently occurring tumor of the eyelids. Among BCC cases, there is a subtype of aggressive cases called horrifying BCC (HBCC). There are also rare BCC cases that show neuroendocrine differentiation. Here, we describe a case of HBCC with neuroendocrine differentiation. The patient, a 41-year-old woman, presented with abnormal left eye tearing an...

full text

Immunohistochemical Evaluation of Fascin in Oral Squamous Cell Carcinoma

Background and purpose: Squamous cell carcinoma (SCC) is the eighth most common cancer in men and the fifteenth in women. Localized recurrence and metastasis to regional lymph nodes are major problems in these patients. Fascin is a 55- kDa protein from the family of actin-binding proteins that is expressed in cells with membranous bronchial tubes. The aim of this study was to evaluate the expre...

full text

Evaluation of Subclinical Extension of Basal Cell Carcinoma

BACKGROUND Basal cell carcinoma (BCC) is the most common malignancy with increasing incidence worldwide. The tumor invades surrounding tissues in an irregular pattern via subclinical and microscopic finger-like growths known as subclinical extension. Subclinical extension may be responsible for incomplete resection of the tumor. This study investigates the subclinical extension of BCC. METHOD...

full text

The Evaluation of Dermoscopic Findings in Basal Cell Carcinoma

Introduction: Many surface microscopy features of pigmented BCCs have been described. The purpose of this study was to review dermoscopic findings of BCC and to investigate their incidence in different dermatopathological subtypes. Material and Methods: Dermoscopic examination of 130 skin lesions in 113 patients with the preliminary diagnosis of BCC, without knowledge of the dermatopathological...

full text

Comparison of COX2 expression in radiation induced basal cell carcinoma and non-radiation induced basal cell carcinoma

Background: Radiation-induced basal cell carcinoma (BCC) can be multiple, large, and recurring, which complicates its treatment in some cases. According to reports on the role of cyclooxygenase 2 (COX2) inhibitors in the treatment or prevention of non-melanoma skin cancers and considering the fact that COX2 expression has not been evaluated in radiation-in...

full text

The Usefulness of CD10 in Distinguishing between Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma

Background & Objectives:  CD10 is a cell surface enzyme with metalloendopeptidase activity, also known as Common Acute Lymphoblastic Leukaemia Antigen, which mainly serves as a marker for acute lymphoblastic leukemia (ALL). To date and to the best of our knowledge, only few comparative immunohistochemical studies have assessed CD10 expression in cutaneous epithelial neoplasms. Our goal was to d...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 14  issue 3

pages  193- 196

publication date 2019-08-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023